Auxier Asset Management Pfizer Inc Transaction History

Auxier Asset Management

$672 Million
Q3 2024

A detailed history of Auxier Asset Management transactions in Pfizer Inc stock. As of the latest transaction made, Auxier Asset Management holds 68,253 shares of PFE stock, worth $1.79 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

68,253

Previous 68,778 0.76%

Holding current value

$1.79 Million

Previous $1.92 Million 2.65%

% of portfolio

0.29%

Previous 0.31%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$27.7 - $31.39 $14,542 - $16,479	-525 Reduced 0.76%	68,253 $1.98 Million
Q2 2024 Aug 13, 2024	BUY	$25.26 - $29.6 $6,138 - $7,192	243 Added 0.35%	68,778 $1.92 Million
Q1 2024 May 08, 2024	SELL	$25.89 - $29.73 $77,540 - $89,041	-2,995 Reduced 4.19%	68,535 $1.9 Million
Q4 2023 Feb 22, 2024	SELL	$26.13 - $33.94 $14,894 - $19,345	-570 Reduced 0.79%	71,530 $2.06 Million
Q3 2023 Nov 21, 2023	SELL	$32.09 - $37.51 $8,022 - $9,377	-250 Reduced 0.35%	72,100 $2.39 Million
Q2 2023 Aug 17, 2023	BUY	$36.12 - $41.79 $168,463 - $194,908	4,664 Added 6.89%	72,350 $2.65 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $26,391 - $34,357	670 Added 1.0%	67,686 $2.76 Million
Q4 2022 Feb 17, 2023	SELL	$41.75 - $54.5 $35,487 - $46,325	-850 Reduced 1.25%	67,016 $3.44 Million
Q3 2022 Nov 15, 2022	SELL	$43.76 - $53.42 $68,353 - $83,442	-1,562 Reduced 2.25%	67,866 $2.97 Million
Q2 2022 Aug 11, 2022	SELL	$46.53 - $55.17 $36,758 - $43,584	-790 Reduced 1.13%	69,428 $3.64 Million
Q1 2022 May 17, 2022	SELL	$45.75 - $56.69 $226,691 - $280,898	-4,955 Reduced 6.59%	70,218 $3.64 Million
Q4 2021 Mar 01, 2022	SELL	$41.32 - $61.25 $24,709 - $36,627	-598 Reduced 0.79%	75,173 $4.44 Million
Q3 2021 Nov 18, 2021	SELL	$39.25 - $50.42 $25,512 - $32,773	-650 Reduced 0.85%	75,771 $3.26 Million
Q2 2021 Aug 18, 2021	SELL	$35.91 - $40.68 $105,216 - $119,192	-2,930 Reduced 3.69%	76,421 $2.99 Million
Q1 2021 May 17, 2021	SELL	$33.49 - $37.77 $190,055 - $214,344	-5,675 Reduced 6.67%	79,351 $2.88 Million
Q4 2020 Mar 05, 2021	SELL	$33.47 - $42.56 $3,347 - $4,256	-100 Reduced 0.12%	85,026 $3.13 Million
Q3 2020 Mar 05, 2021	BUY	$31.75 - $37.25 $14,382 - $16,874	453 Added 0.53%	85,126 $3.12 Million
Q2 2020 Aug 20, 2020	BUY	$30.12 - $36.54 $343,518 - $416,738	11,405 Added 15.57%	84,673 $2.77 Million
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $24,245 - $34,642	-897 Reduced 1.21%	73,268 $2.39 Million
Q4 2019 Feb 21, 2020	SELL	$32.92 - $37.36 $27,521 - $31,232	-836 Reduced 1.11%	74,165 $2.91 Million
Q3 2019 Nov 15, 2019	BUY	$32.49 - $42.13 $682 - $884	21 Added 0.03%	75,001 $2.7 Million
Q2 2019 Aug 15, 2019	BUY	$36.98 - $41.52 $65,639 - $73,698	1,775 Added 2.42%	74,980 $3.25 Million
Q1 2019 May 14, 2019	BUY	$37.5 - $41.2 $42,187 - $46,350	1,125 Added 1.56%	73,205 $3.11 Million
Q4 2018 Feb 13, 2019	SELL	$38.47 - $43.86 $146,186 - $166,668	-3,800 Reduced 5.01%	72,080 $3.15 Million
Q3 2018 Nov 19, 2018	SELL	$34.47 - $41.81 $10,341 - $12,543	-300 Reduced 0.39%	75,880 $3.34 Million
Q2 2018 Aug 15, 2018	SELL	$32.98 - $35.16 $69,258 - $73,836	-2,100 Reduced 2.68%	76,180 $2.76 Million
Q1 2018 May 14, 2018	SELL	$31.91 - $37.02 $10,785 - $12,512	-338 Reduced 0.43%	78,280 $2.78 Million
Q4 2017 Feb 14, 2018	SELL	$33.26 - $35.29 $81,487 - $86,460	-2,450 Reduced 3.02%	78,618 $2.85 Million
Q3 2017 Nov 09, 2017	SELL	$31.0 - $34.15 $142,600 - $157,090	-4,600 Reduced 5.37%	81,068 $2.89 Million
Q2 2017 Aug 16, 2017	BUY	N/A	85,668	85,668 $2.88 Million

Others Institutions Holding PFE

# of Institutions

3,258

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $147B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Auxier Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Auxier Asset Management with notifications on news.

Account

Auxier Asset Management Pfizer Inc Transaction History